InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Browse the detailed record of transactions filed by Pierce Christopher, Chief Executive Officer. Officer active across 1 company, notably Prelude Therapeutics Inc. In total, 1 filings have been published. History available since 2 September 2021. The latest transaction was disclosed on 2 September 2021 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Pierce Christopher
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
17,000 shares@ US$12.85100.0% of flowCommon StockSEC:0001209191-21-055072:0
1 of 1 declaration
About Pierce Christopher
Christopher Pierce is the Executive Vice President and Chief of Business Operations of Prelude Therapeutics Inc. He oversees business operations and contributes to the company's strategy.
